1578-2190

Actas Dermo-Sifiliográficas (English Edition)

Elsevier

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 3164 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact3164 DOIs
2

Attach ORCID iDs across 3164 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact3164 DOIs
3

Deposit reference lists for 221 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact221 DOIs

DOIs for this ISSN

Showing the top 5 of 3164 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Using the Common Terminology Criteria for Adverse Events (CT… (10.1016/j.adengl.2019.05.021)
Abstract ORCID
100.43 101
2 Leprosy. An Update: Definition, Pathogenesis, Classification… (10.1016/j.adengl.2012.03.028)
Abstract ORCID
81.67 42
3 Recurrent Aphthous Stomatitis (10.1016/j.adengl.2019.09.006)
Abstract ORCID
73.86 29
4 Hair Cosmetics: Dyes (10.1016/j.adengl.2014.02.003)
Abstract ORCID
69.01 23
5 Psoriasis and Depression: The Role of Inflammation (10.1016/j.adengl.2018.05.035)
Abstract ORCID
69.01 23
6 Dermal Fillers: Types, Indications, and Complications (10.1016/s1578-2190(10)70660-0)
Abstract ORCID
67.12 21
7 Cutaneous and Mucocutaneous Leishmaniasis (10.1016/j.adengl.2021.05.011)
Abstract ORCID
66.11 20
8 Guidelines for the Use of Acitretin in Psoriasis (10.1016/j.adengl.2013.01.001)
Abstract ORCID
65.05 19
9 The Role of Filaggrin in the Skin Barrier and Disease Develo… (10.1016/j.adengl.2014.12.007)
Abstract ORCID
65.05 19
10 Update on the Classification and Treatment of Localized Scle… (10.1016/j.adengl.2012.10.012)
Abstract ORCID
63.94 18
11 Ultrasound Skin Imaging (10.1016/j.adengl.2014.10.002)
Abstract ORCID
62.76 17
12 Platelet-Rich Plasma: Applications in Dermatology (10.1016/j.adengl.2014.12.009)
Abstract ORCID
61.52 16
13 Spanish Evidence-Based Guidelines on the Treatment of Psoria… (10.1016/j.adengl.2013.04.013)
Abstract ORCID
60.21 15
14 Implementation and Operation of an Integrated Quality Manage… (10.1016/j.adengl.2019.01.003)
Abstract ORCID
60.21 15
15 Clinical and Therapeutic Profile and Quality of Life of Pati… (10.1016/s1578-2190(07)70491-2)
Abstract ORCID
60.21 15
16 Translation and Cross-Cultural Adaptation of Health Assessme… (10.1016/j.adengl.2018.02.003)
Abstract ORCID
58.80 14
17 Preoperative 15-MHz Ultrasound Assessment of Tumor Thickness… (10.1016/j.adengl.2012.06.025)
Abstract ORCID
57.31 13
18 Obesity and Psoriasis: Inflammatory Nature of Obesity, Relat… (10.1016/j.adengl.2012.08.024)
Abstract ORCID
57.31 13
19 Burnout Syndrome and Demotivation Among Health Care Personne… (10.1016/j.adengl.2016.03.003)
Abstract ORCID
57.31 13
20 Paradoxical Reactions to Biologic Therapy in Psoriasis: A Re… (10.1016/j.adengl.2018.09.012)
Abstract ORCID
57.31 13
21 Porokeratosis: A Review of its Pathophysiology, Clinical Man… (10.1016/j.adengl.2020.08.005)
Abstract ORCID
57.31 13
22 Update on Photoprotection (10.1016/s1578-2190(10)70696-x)
Abstract ORCID
57.31 13
23 Tofacitinib and Other Kinase Inhibitors in the Treatment of… (10.1016/j.adengl.2013.03.002)
Abstract ORCID
55.70 12
24 Allergic Contact Dermatitis Due to Paraphenylenediamine: An… (10.1016/j.adengl.2018.06.017)
Abstract ORCID
55.70 12
25 Clinical Management of Cutaneous Adverse Events in Patients… (10.1016/j.adengl.2019.05.003)
Abstract ORCID
55.70 12
26 Autosomal Recessive Congenital Ichthyosis (10.1016/j.adengl.2011.11.021)
Abstract ORCID
53.96 11
27 Skin Cancer Incidence and Mortality in Spain: A Systematic R… (10.1016/j.adengl.2016.02.015)
Abstract ORCID
53.96 11
28 Leukemia Cutis: A Report of 17 Cases and a Review of the Lit… (10.1016/j.adengl.2016.08.014)
Abstract ORCID
53.96 11
29 Photodynamic Therapy With Methylene Blue for Skin Ulcers Inf… (10.1016/j.adengl.2017.05.010)
Abstract ORCID
53.96 11
30 Doxycycline, an antibiotic or an anti-inflammatory agent? Th… (10.1016/j.adengl.2019.12.014)
Abstract ORCID
53.96 11
31 Estimated Effect of COVID-19 Lockdown on Skin Tumor Size and… (10.1016/j.adengl.2020.09.008)
Abstract ORCID
53.96 11
32 Dermoscopy in Basal Cell Carcinoma: An Updated Review (10.1016/j.adengl.2021.01.023)
Abstract ORCID
53.96 11
33 Key Diagnostic Features and Treatment of Subungual Glomus Tu… (10.1016/s1578-2190(09)70558-x)
Abstract ORCID
53.96 11
34 Allergic Contact Dermatitis Caused by Formaldehyde and Forma… (10.1016/s1578-2190(11)70765-x)
Abstract ORCID
53.96 11
35 Contact Sensitization to Allergens in the Spanish Standard S… (10.1016/j.adengl.2011.07.008)
Abstract ORCID
52.07 10
36 Drug-Induced Lupus Erythematosus (10.1016/j.adengl.2012.09.025)
Abstract ORCID
52.07 10
37 Health-Related Quality of Life, Patient Satisfaction, and Ad… (10.1016/j.adengl.2013.04.004)
Abstract ORCID
52.07 10
38 Allergic Contact Dermatitis Caused by Cosmetic Products (10.1016/j.adengl.2014.09.007)
Abstract ORCID
52.07 10
39 Calcinosis Cutis and Calciphylaxis (10.1016/j.adengl.2015.10.018)
Abstract ORCID
52.07 10
40 Methotrexate in Moderate to Severe Psoriasis: Review of the… (10.1016/j.adengl.2016.01.025)
Abstract ORCID
52.07 10
41 Sweet Syndrome: A Review and Update (10.1016/j.adengl.2016.05.021)
Abstract ORCID
52.07 10
42 Impact of Vitiligo on Quality of Life (10.1016/j.adengl.2017.06.001)
Abstract ORCID
52.07 10
43 Preservatives in Personal Hygiene and Cosmetic Products, Top… (10.1016/j.adengl.2017.07.003)
Abstract ORCID
52.07 10
44 Vitamin D and the Skin: A Review for Dermatologists (10.1016/j.adengl.2019.04.001)
Abstract ORCID
52.07 10
45 Juvenile Xanthogranuloma: An Entity With a Wide Clinical Spe… (10.1016/j.adengl.2020.10.007)
Abstract ORCID
52.07 10
46 Malignant Syphilis: A Systematic Review of the Case Reports… (10.1016/j.adengl.2021.05.014)
Abstract ORCID
52.07 10
47 Xerosis: a Dysfunction of the Epidermal Barrier (10.1016/s1578-2190(08)70343-3)
Abstract ORCID
52.07 10
48 Lichen Sclerosus and Squamous Cell Carcinoma (10.1016/j.adengl.2011.05.004)
Abstract ORCID
50.00 9
49 Cutaneous Metastases of Internal Tumors (10.1016/j.adengl.2012.06.031)
Abstract ORCID
50.00 9
50 High-Risk Cutaneous Squamous Cell Carcinoma (10.1016/j.adengl.2012.08.004)
Abstract ORCID
50.00 9